Titan Biotech Limited (BOM:524717)

Titan Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	8,166	3,484	4,365	1,627	2,166	1,533
Market Cap Growth	26.69%	-20.19%	168.33%	-24.88%	41.23%	335.05%
Enterprise Value	8,218	3,409	4,405	1,665	2,381	1,592
Last Close Price	988.15	420.64	525.45	194.81	257.96	181.86
PE Ratio	35.41	16.18	17.56	6.55	9.99	5.06
PS Ratio	4.68	2.23	2.66	1.13	1.75	1.08
PB Ratio	4.91	2.27	3.27	1.48	2.51	2.12
P/TBV Ratio	4.91	2.27	3.27	1.48	2.51	2.23
P/FCF Ratio	56.94	32.39	262.72	19.26	13.77	9.54
P/OCF Ratio	39.26	17.31	20.64	7.68	9.82	8.04
EV/Sales Ratio	4.72	2.18	2.69	1.16	1.93	1.12
EV/EBITDA Ratio	27.59	13.75	13.09	5.76	7.74	3.46
EV/EBIT Ratio	32.33	16.15	14.30	6.21	8.26	3.60
EV/FCF Ratio	57.30	31.70	265.13	19.72	15.14	9.91
Debt / Equity Ratio	0.05	0.02	0.07	0.08	0.10	0.22
Debt / EBITDA Ratio	0.32	0.13	0.26	0.29	0.29	0.34
Debt / FCF Ratio	0.62	0.30	5.27	1.01	0.57	1.00
Asset Turnover	0.93	0.94	1.13	1.19	1.18	1.61
Inventory Turnover	1.79	1.54	1.88	2.01	1.78	2.13
Quick Ratio	1.03	1.37	1.12	1.27	1.37	1.22
Current Ratio	2.78	4.46	3.71	3.36	3.76	3.05
Return on Equity (ROE)	14.81%	15.01%	20.42%	25.33%	27.32%	55.61%
Return on Assets (ROA)	7.64%	7.95%	13.21%	13.81%	17.25%	31.25%
Return on Invested Capital (ROIC)	10.97%	11.35%	18.54%	20.66%	25.17%	44.76%
Return on Capital Employed (ROCE)	13.50%	13.40%	22.40%	23.50%	31.60%	54.30%
Earnings Yield	2.82%	6.18%	5.69%	15.27%	10.01%	19.78%
FCF Yield	1.76%	3.09%	0.38%	5.19%	7.26%	10.48%
Dividend Yield	0.20%	0.47%	0.38%	0.92%	0.58%	0.83%
Payout Ratio	7.17%	7.68%	5.99%	4.99%	5.72%	2.72%
Buyback Yield / Dilution	-0.02%	-	-	-	-	-
Total Shareholder Return	0.19%	0.47%	0.38%	0.92%	0.58%	0.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.